Mei Ri Jing Ji Xin Wen·2025-11-24 22:49Group 1: Major Tech Stocks Performance - Major tech stocks showed a positive trend, with Tesla rising by 6.36%, Google by 5.49%, Facebook by 3.37%, Amazon by 2.51%, Apple by 0.83%, Microsoft by 0.6%, and Nvidia by 0.2% [2][3] - The Philadelphia Semiconductor Index surged by 3.66%, with Broadcom increasing over 9%, Micron Technology up 6.71%, Supermicro up 4.05%, and Intel rising by 3.57% [2][3] Group 2: Novo Nordisk's Clinical Trial Results - Novo Nordisk experienced a significant drop of 6.58%, with shares once down nearly 10% following the announcement of late-stage trial results for semaglutide in Alzheimer's disease, which did not meet its efficacy targets [5][6] - The trials indicated that there was no significant improvement in cognitive decline among thousands of participants, with the goal being to slow cognitive decline by at least 20% [5][6] Group 3: Nasdaq China Golden Dragon Index - The Nasdaq China Golden Dragon Index rose by 2.56%, with notable individual stock performances including Hesai Technology up over 18%, Canadian Solar up nearly 9%, Baidu up 7.84%, and Bilibili up 6.96% [8][9] Group 4: Market Outlook and Predictions - Morgan Stanley's chief U.S. equity strategist, Michael Wilson, expressed optimism about the U.S. stock market, suggesting that the recent downturn may soon end and reaffirming a positive outlook for next year [10] - Wilson predicts that the S&P 500 index could rebound to 7800 points in a year, representing an approximate 18% increase from current levels, driven by a potential Fed rate cut cycle and AI-driven efficiency improvements [11] - Goldman Sachs anticipates that the Fed will implement a third consecutive rate cut in December, with expectations of further cuts in 2026, as inflation eases and the labor market cools [11][12]